These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10616185)

  • 21. New European guidance on borderline products.
    Donawa ME;
    Med Device Technol; 2009 Sep; 20(5):22, 24-5. PubMed ID: 19852178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Industry perspective for biotech products.
    Möritz A
    Dev Biol (Basel); 2004; 118():37-44. PubMed ID: 15645671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health impact assessment: assessing opportunities and barriers to intersectoral health improvement in an expanded European Union.
    Lock K; McKee M
    J Epidemiol Community Health; 2005 May; 59(5):356-60. PubMed ID: 15831682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICH activities on biotech topics.
    Zorzi-Morre P
    Dev Biol Stand; 1999; 100():151-3. PubMed ID: 10616186
    [No Abstract]   [Full Text] [Related]  

  • 25. EEC guidelines on medicinal products derived from modern biotechnological processes.
    Sauer F
    J Biol Stand; 1989 Jul; 17(3):201-2. PubMed ID: 2793872
    [No Abstract]   [Full Text] [Related]  

  • 26. [Time for Sweden to recognize the right to health care in other European Union countries].
    Bernitz U; Lokrantz-Bernitz B
    Lakartidningen; 2005 Nov 28-Dec 4; 102(48):3709-10. PubMed ID: 16416951
    [No Abstract]   [Full Text] [Related]  

  • 27. Transposing the E. E. U. Blood Directive into national law. Perspective of Slovenia.
    Potocnik M
    Transfus Clin Biol; 2005 Feb; 12(1):21-4. PubMed ID: 15814288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Briefing on current and future developments in European Union policy and practice in healthcare.
    Fahy N
    Health Serv Manage Res; 2012 Aug; 25(3):152-3. PubMed ID: 23135890
    [No Abstract]   [Full Text] [Related]  

  • 29. The compatibility of standardisation and innovation.
    Moore R
    Med Device Technol; 2004 Nov; 15(9):28. PubMed ID: 16231785
    [No Abstract]   [Full Text] [Related]  

  • 30. Worldwide perspective in transfusion safety: Europe.
    Reesink HW; Strengers PE
    Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107
    [No Abstract]   [Full Text] [Related]  

  • 31. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 32. The emerging mental health strategy of the European Union: a multi-level work-in-progress.
    Kelly BD
    Health Policy; 2008 Jan; 85(1):60-70. PubMed ID: 17643547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Policies for disease prevention in Germany in the European context: a comparative analysis.
    Gericke CA; Busse R
    J Public Health (Oxf); 2004 Sep; 26(3):230-8. PubMed ID: 15454589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing new European vigilance procedures.
    Donawa M
    Med Device Technol; 2007; 18(7):34, 36-7. PubMed ID: 18075133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healing Europe's ailing health centres in an enlarged European Union. An interview with professor Per-Gunnar Svensson. Interview by Kellie Peakman.
    Svensson PG
    World Hosp Health Serv; 2004; 40(2):14-5. PubMed ID: 15338992
    [No Abstract]   [Full Text] [Related]  

  • 36. An industry perspective on plasma-derived products.
    von Hoegen I
    Dev Biol (Basel); 2004; 118():31-5. PubMed ID: 15645670
    [No Abstract]   [Full Text] [Related]  

  • 37. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns].
    Cianciara D
    Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood components: current challenges.
    Rouger P
    Transfus Clin Biol; 2007 Dec; 14(6):496-8. PubMed ID: 18420438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Will the right to the protection of health be a real one in the future European Union?
    Reverte-Cejudo D; Sanchez-Bayle M
    J Epidemiol Community Health; 2005 Mar; 59(3):181. PubMed ID: 15709074
    [No Abstract]   [Full Text] [Related]  

  • 40. The CREATE project: a new beginning of allergen standardization based on mass units of major allergens.
    van Ree R
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):70-3; discussion 74-5. PubMed ID: 15119023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.